ARTICLE
8 February 2024

Medicare Advantage Risk Adjustment Data Validation Final Rule

RD
Riker Danzig LLP

Contributor

Riker Danzig LLP has served the business community for 140 years, with offices in Morristown and Trenton, New Jersey and in Midtown Manhattan. Riker Danzig is regional counsel, national defense counsel, and deal counsel to clients ranging from Fortune 500 corporations to middle-market businesses.
The U.S. Department of Health and Human Services ("HHS"), through the Centers for Medicare & Medicaid Services ("CMS"), issued a final rule early last year which...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The U.S. Department of Health and Human Services ("HHS"), through the Centers for Medicare & Medicaid Services ("CMS"), issued a final rule early last year which, among other things, implemented stricter audits of Medicare Advantage plans, by striking the fee-for-service adjuster from risk adjustment data validation audits. The rule implements changes to the Medicare Advantage Risk Adjustment Data Validation ("RADV") program, which CMS uses to recover improper risk adjustment payments made to Medicare Advantage ("MA") plans.

CMS stated in the corresponding Fact Sheet that the RADV final rule will help CMS to protect the MA program by "addressing instances where Medicare paid Medicare Advantage Organizations ("MAOs") more than they otherwise should have received because the medical diagnoses submitted for risk adjustment payment were not supported in the beneficiary's medical record." Specifically, the final rule changed that, as part of the RADV audit methodology, CMS would extrapolate RADV audit findings beginning with payment year 2018. The final rule estimates that the government would not start to collect recoveries for 2018 payments until 2025. CMS reasoned that the final rule protects the program from exploitation through practices such as upcoding schemes.

A year into this final rule, it is likely that entities should start seeing an uptick in audit activity. The full text of the final rule may be accessed here. The audit process itself was modified as explained in our January 16, 2024 blog post.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
8 February 2024

Medicare Advantage Risk Adjustment Data Validation Final Rule

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Riker Danzig LLP has served the business community for 140 years, with offices in Morristown and Trenton, New Jersey and in Midtown Manhattan. Riker Danzig is regional counsel, national defense counsel, and deal counsel to clients ranging from Fortune 500 corporations to middle-market businesses.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More